1685TiP Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): A multicenter randomized controlled trial von van Dam, J.L., Verkolf, E.M.M., Dekker, E.N., van Tienhoven, G., Homs, M.Y.V., Besselink, M.G., Wilmink, H.W., Groot Koerkamp, B.

Volltext

10-year survival after resection of pancreatic ductal adenocarcinoma is only 2% in nationwide cohort von Verkolf, E.M.M., van der Geest, L.G., de Wilde, R.F., Doukas, M., Groot Koerkamp, B.

Volltext

Prediction of Resection after Initial FOLFIRINOX for Localized Pancreatic Adenocarcinoma: A Trans-Atlantic Pancreatic Surgery (TAPS) Consortium Study von Verkolf, E.M.M., Van Dam, J.L., Dekker, E.N., Prakash, L.R., DeSilva, A., Besselink, M.G., Wei, A.C., Zureikat, A.H., Katz, M.H., Tzeng, C.-W.D., Groot Koerkamp, B.

Volltext

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial von Dam, J.L. van, Verkolf, E.M.M., Dekker, E.N., Bonsing, B.A., Bratlie, S.O., Brosens, L.A.A., Busch, O.R., Driel, L.M.J.W. van, Eijck, C.H.J. van, Feshtali, S., Ghorbani, P., Groot, D.J.A. de, Groot, J.W.B. de, Haberkorn, B.C.M., Hingh, I.H. de, Holt, B. van der, Karsten, T.M., Kolk, M.B. van der, Labori, K.J., Liem, M.S.L., Loosveld, O.J.L., Molenaar, I.Q., Polee, M.B., Santvoort, H.C. van, Geelen, J.D., Wumkes, M.L., Tienhoven, G. van, Homs, M.Y.V., Besselink, M.G., Wilmink, J.W., Koerkamp, B.G.

Volltext bestellen